NSCLC: Staging and TNM classification

Slides:

Advertisements

Similar presentations

TNM staging and prognosis Alexandru Eniu, MD, PhD Medical Oncologist Department of Breast Tumors Cancer Institute Ion Chiricuţă Cluj-Napoca, Romania.

Advertisements

Module 6: Clinical Stage and Grade. Introduction Stage and grade determine prognosis Staging reflects the clinical extent of the tumor Grading a tumor.

STAGING MCR Staff Show Me Healthy Women March 27, 2008 Supported by a Cooperative Agreement between DHSS and the Centers for Disease Control and Prevention.

What is TNM? TNM is a system for classifying malignant tumours ! It is a cancer staging system, which describes the extent of a person's cancer ! Most.

Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.

Cancer Staging. What is cancer staging? Staging describes the severity of a person’s cancer based on the extent of the original (primary) tumor and whether.

Staging and Grading of cancers By Haleigh Nelson.

AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #3 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.

Gallbladder Cancer Reham Khalilieh 4 th year Medical Student Surgical Round- Shaare Zedek Medical Center, Jerusalem.

Neoplasia. 3- Rate of growth  Most benign tumours grow slowly over a period of years, whereas most cancers grow rapidly, spread locally and to distant.

SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,

PRESENTING LUNG CANCER. Lung Cancer: Defined  Uncontrolled growth of malignant cells in one or both lungs and tracheo-bronchial tree  A result of repeated.

Slides last updated: March 2015 CRC: STAGING. How colorectal cancer (CRC) is staged 1 Stage describes the extent of cancer, and is one of the most important.

Cancer Staging.

강 창 현 서울대학교병원 흉부외과 서울대학교 의과대학. Staging Communication Evaluation TreatmentPrognosis Research.

Principles of Surgical Oncology Salah R. Elfaqih.

Metastatic Cancer – Gross Pathology Lymph node - metastasis from breastLiver – metastasis from lung Vertebral column – metastasis from prostate Mesentery.

TNM BLADDER CANCER STAGING Dr. Mahnaz Roayaei Radiation Oncologist Assistant Professor Isfahan University of Medical Sciences.

Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)

Melanoma of the Skin Regional lymph nodes for skin sites of the head and neck. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd.

Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.

BRONCHOIAL TUMOURS.

Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry

Lecture # 42 NEOPLASIA - 3 Dr

Section 1 Populations at Risk, Assessment  Cell Cycle:  Mitosis- orderly well regulated growth.

ajcc TNM Staging: chapter 1, and Summary stage

Collaborative Staging for Colon Site Specific Factors Tonya Brandenburg, MHA, CTR QA Manager Abstracting and Coding Kentucky Cancer Registry.

IMAGING FINDINGS - The NSCLC stage classification is based on the TNM system: - T: extent of the primary tumor - N: extent of regional lymph node involvement.

Staging System and Excision Types Tae Won Kim, MD PCOM Tumor Review

PATHOLOGY OF NECK DISSECTION. VIEW FROM DEEP ASPECT OF NECK DISSECTION.

Cancer: Staging and Grading What is meant by the term “biopsy”? How do tumors behave differently from one another ? Examples of the stages of cancer and.

CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.

Brain imaging prior to lung cancer resection

THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE

The IASLC Lung Cancer Staging Project The 8th Edition

Underwriting Breast Cancer

CAMELYON17: Moving the challenge to patient level

Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma Yingjie.

Principles of Surgical Oncology

UNDERWRITING CANCER OUR WAY OR THE LONG WAY

Cancer Cancer – A general term for more than 250 diseases characterized by abnormal and uncontrolled growth of cells.

DENİZ KAVGACI HALİME HELİN YILMAZ

Neuro-Endocrine Tumoren De Appendix in het Bijzonder

Staging Cancer.

معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.

Proposed Changes to the 7th Edition

What’s New for 8th Edition

Cancer Staging.

Utility of 99mTc-PEG4-E[PEG4-c(RGDfK)]2 in Posttherapy Surveillance of Patients with Reelevated Carcinoembryonic.

Dr T P E Wells 13 July 2018 Breast SSG Bath

TNM 8 UPDATE Head and Neck SSG March 2018

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

Lung cancer staging and TNM classification

흉부영상집답회 case review 강동경희대병원 이한나.

Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non–Small Cell Lung Cancer in the U.S. National Cancer Data Base

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Prognostic Impact of Preoperative Tumor Marker Levels and Lymphovascular Invasion in Pathological Stage I Adenocarcinoma and Squamous Cell Carcinoma of.

Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma Yingjie.

Prognostic Impact of Preoperative Tumor Marker Levels and Lymphovascular Invasion in Pathological Stage I Adenocarcinoma and Squamous Cell Carcinoma of.

Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer Elaine Y.L. Leung, MB ChB,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer Ryo Maeda, MD, Junji Yoshida, MD, PhD, Genichiro Ishii, MD, PhD,

Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Kemp H Kernstine, MD, PhD, Kelley A McLaughlin,

Changes in TNM 8 To be used from

NSCLC: Epidemiology and disease characteristics

NSCLC: Epidemiology and disease characteristics

Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.

Detection of E-cadherin fragments in human prostate cancer metastases.

Presentation transcript:

NSCLC: Staging and TNM classification NSCLC, non-small cell lung cancer; TNM, tumour, node, metastasis.

Lung cancer staging and TNM classification1 The most frequently used system to stage lung cancer is the American Joint Committee on Cancer TNM system, which is based on: The size and extent of the primary tumour (T) Whether the cancer has spread to nearby (regional) lymph nodes (N) Whether the cancer has metastasised (M) to other organs of the body Once the T, N and M categories have been defined, this information is combined to assign an overall stage of 0, I, II, III or IV This process is called stage grouping It produces a range of anatomical stage or prognostic groups (right) T1mi, minimally invasive adenocarcinoma; Tis, tumour in situ; TNM, tumour, node, metastasis. 1. American Joint Committee on Cancer. Lung cancer staging. 8th ed. 2017. https://cancerstaging.org/references-tools/Pages/Cancer-Staging-Resources.aspx (Accessed: 07 December 2018).

Lung cancer TNM classification explained1 *There is no designation of MX. The absence of any clinical history or physical findings suggestive of metastases in a patient who has not undergone any imaging is sufficient to assign the clinical M0 category. There is no designation of pM0. Biopsy or other pathological information is required to assign the pathological M1 category. Patients with a negative biopsy of a suspected metastatic site are classified as clinical M0 (cM0). cM, clinical metastasis; pM, pathological metastasis; TNM, tumour, node, metastasis. 1. American Joint Committee on Cancer. Lung cancer staging. 8th ed. 2017. https://cancerstaging.org/references-tools/Pages/Cancer-Staging-Resources.aspx (Accessed: 07 December 2018).